Tag: "mgh" at medical news

MGH researchers find way of regenerating cells key to hearing

Selectively turning off a protein that controls the growth and division of cells could allow regeneration of the inner ear's hair cells, which convert sound vibrations into nerve impulses. The discovery by a research team based at Massachusetts General Hospital (MGH) runs counter to current beliefs about these cells and could eventually lead to ways of preventing or treating hearing loss. The r...

MGH study details brain changes in autism, language disorder

Using advanced imaging technology, a research team based at Massachusetts General Hospital (MGH) has identified specific portions of the brain's white matter that are abnormally large in children with autism and developmental language disorder (DLD). The findings confirm that the previously observed overgrowth of white matter occurs after birth and suggest that it may be related to the process o...

Hazing underrecognized as cause of serious injury, says MGH physician

Young people and others who are injured in hazing incidents should be regarded as victims of crimes in their treatment by health care professionals, says an emergency physician at Massachusetts General Hospital (MGH). In a report in the May issue of the American Journal of Emergency Medicine, Michelle Finkel, MD, also notes that hazing victims may disguise the true cause of their injuries out of...

MGH study identifies key immune system molecule

Researchers from MassGeneral Hospital for Children have identified a molecule that is key to how white blood cells called macrophages recognize the common bacteria E. coli. The study, which may lead to better ways of fighting infections, is being issued on March 24 as an advance online publication of the journal Nature. It will appear in a future print edition of the journal. ......The body's i...

MGH study finds herceptin has additional antitumor qualities

Scientists at Massachusetts General Hospital (MGH) have discovered powerful anti-angiogenic properties in herceptin, a monoclonal antibody used to fight certain forms of breast cancer. Herceptin is known to block the cell receptor HER2 on breast cancer cells and is used to treat women whose tumors produce extra copies of HER2, a more aggressive form of cancer. The new data show that herceptin...

$3 million gift from Purdue Pharma to support MGH Pain Program

A significant gift to the Massachusetts General Hospital from Purdue Pharma L.P. of Stamford, Conn., will support a range of programs aimed at improving the understanding and management of the most common symptom of illness and injury - pain. The $3 million commitment from the Purdue Pharma Fund will be used to develop and expand opportunities for health care professionals to learn more about th...

MGH researchers identify angiogenesis inhibitor in gallbladder cancer

.Researchers at the Massachusetts General Hospital (MGH) have discovered that a.cellular growth factor called TGF-beta-1 has a previously unsuspected role in.regulating the growth of blood vessels associated with metastatic gallbladder.cancer. They also report finding that, in animal studies of the development of.blood vessels (angiogenesis) associated with cancer, model systems in which.tumor...

MGH study shows mitral valve prolapse not a stroke risk factor

.Researchers from the Massachusetts General Hospital report that mitral valve.prolapse, an abnormality of a heart valve, does not appear to be associated with.an increased risk of stroke among young people. Earlier studies, many using.outdated imaging techniques, had led to the belief that mitral valve prolapse.was a significant risk factor for stroke. . .The MGH report appears in the July 1 N...
(Date:4/17/2014)... LSTM have called for more research to be ... children in sub-Saharan Africa. In a paper in ... Russell Stothard, working with colleagues in the department ... University, in Cleveland Ohio, University of Cambridge and ... into the joint burden of HIV/AIDS and schistosomiasis ...
(Date:4/16/2014)... NJ (April 16, 2014): Celldex Therapeutics, Inc. (NASDAQ: ... 1 study of CDX-1401 in solid tumors, including long-term ... Medicine (Vol 6 Issue 232). The data demonstrate ... clinical benefit in patients with very advanced cancers and ...
(Date:4/16/2014)... While it is well known that fertility treatments are ... that multiples are at elevated risk of premature birth, ... Fertility and Sterility . The article ... reduce the odds of multiple births and prematurity, including ...
(Date:4/15/2014)... medical mystery and in the process have found a potentially ... 1.5 million people a year. The researchers say they now understand ... been in use for more than 50 years even though ... to the microbes it attacks. , A report of ...
(Date:4/14/2014)... been made in chemotherapy over the past decade, but ... continues to be a major challenge. , Nanotechnology ... the use of nanocarriers, or capsules, that can transport ... body. , The catch? These carriers are tiny, and ...
Breaking Medicine News(10 mins):Health News:More research called for into HIV and schistosomiasis coinfection in African children 2Health News:Celldex's Phase 1 study of CDX-1401 published in Science Translational Medicine 2Health News:Celldex's Phase 1 study of CDX-1401 published in Science Translational Medicine 3Health News:Celldex's Phase 1 study of CDX-1401 published in Science Translational Medicine 4Health News:Preterm births, multiples, and fertility treatment 2Health News:Preterm births, multiples, and fertility treatment 3Health News:Potent, puzzling and (now less) toxic: Team discovers how antifungal drug works 2Health News:Potent, puzzling and (now less) toxic: Team discovers how antifungal drug works 3Health News:Nano shake-up 2
Other Tags
rufflesglut4harnessingsupercomputingdentistrygrasslandsinventorflamingospresidentbudgetsmeagerstretchscfalternatingconflictingaustralasian